The Effect of Prescription Drug Monitoring Programs on Opioid Utilization in Medicare
NBER Working Paper No. 23148
Issued in February 2017
NBER Program(s):Health Care, Health Economics
The misuse of prescription opioids has become a serious epidemic in the US. In response, states have implemented Prescription Drug Monitoring Programs (PDMPs), which record a patient's opioid prescribing history. While few providers participated in early systems, states have recently begun to require providers to access the PDMP under certain circumstances. We find that "must access" PDMPs significantly reduce measures of misuse in Medicare Part D. In contrast, we find that PDMPs without such provisions have no effect. We find stronger effects when providers are required to access the PDMP under broad circumstances, not only when they are suspicious.
You may purchase this paper on-line in .pdf format
from SSRN.com ($5) for electronic delivery.
A non-technical summary of this paper is available in the 2017 number 2 issue of the NBER Bulletin on Aging and Health. You can sign up to receive the NBER Bulletin on Aging and Health by email.
Machine-readable bibliographic record -
Document Object Identifier (DOI): 10.3386/w23148
Users who downloaded this paper also downloaded* these:
|Alpert, Powell, and Pacula
||w23031 Supply-Side Drug Policy in the Presence of Substitutes: Evidence from the Introduction of Abuse-Deterrent Opioids
|Powell, Pacula, and Taylor
||w21072 How Increasing Medical Access to Opioids Contributes to the Opioid Epidemic: Evidence from Medicare Part D
|Rees, Sabia, Argys, Latshaw, and Dave
||w23171 With a Little Help from My Friends: The Effects of Naloxone Access and Good Samaritan Laws on Opioid-Related Deaths
|Powell, Pacula, and Jacobson
||w21345 Do Medical Marijuana Laws Reduce Addictions and Deaths Related to Pain Killers?
|Hollingsworth, Ruhm, and Simon
||w23192 Macroeconomic Conditions and Opioid Abuse